Advanced Life Sciences to Be Featured at iBIO MarketPlace 2002
Woodridge, Ill, October 4, 2002 - Advanced Life Sciences, Inc. announced
today that it is one of 26 regional biotech companies that will make presentations
at the fourth annual iBIO MarketPlace 2002, the Midwest's premier life sciences business event.
Michael T. Flavin, Ph.D., Chief Executive Officer of Advanced Life Sciences will give the
presentation on Wednesday, Oct. 9, 2002 at 9:30 AM (CST) at the Hyatt Regency, McCormick Place,
Chicago, before an audience of investors, analysts, biotech CEOs, journalists and representatives
of large pharmaceutical companies.
Participating companies are looking for various stages of investment support.
"This event represents a key networking opportunity for investment-seeking biotech companies,
like Advanced Life Sciences, to showcase their technologies before an audience of investors,
analysts, biotech CEOs, journalists and representatives of large pharmaceutical companies also
from the Midwest", said Dr. Flavin.
Based in Woodridge, Illinois, Advanced Life Sciences, Inc. (www.advancedlifesciences.com)
is a privately held biopharmaceutical company that discovers and develops therapeutic compounds
to fight infection, inflammation and cancer. The Company bridges the gap between drug discovery
and pharmaceutical commercialization, and focuses on diseases that have significant unmet medical
needs in important markets.